Skip to main content
letter
. 2018 Jan 25;8(1):1. doi: 10.1038/s41408-017-0043-6

Fig. 1.

Fig. 1

a Overall survival (OS) and b progression free survival (PFS) of DLBCL with and without (w/o) MPM. c OS and d PFS of IPI-defined low risk DLBCL patients with and without MPM. e OS and f PFS of IPI-defined high risk DLBCL patients with and without MPM